Last reviewed · How we verify
reverse hybrid therapy
At a glance
| Generic name | reverse hybrid therapy |
|---|---|
| Also known as | pantoprazole 40mg, amoxicillin 1g, clarithromycin 500mg, metronidazole 500mg, Pantoprazole |
| Sponsor | Kaohsiung Veterans General Hospital. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Gastrointestinal symptoms
- General symptoms
Key clinical trials
- Kuwa Free! - Live Free! (NA)
- Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation (NA)
- Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection (PHASE4)
- 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy (PHASE4)
- Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy (NA)
- Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy. (NA)
- Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt (PHASE4)
- Tailored Juice-guided Eradication Therapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |